H-1B sponsors › C › Contemporaries, Inc.
Does Contemporaries, Inc. sponsor H-1B visas?
U.S. Department of Labor filings, Oct 2025 – Jun 2026.
Roles and salaries on Contemporaries, Inc.'s H-1B filings
| Job title | Filings | Median wage | Middle 50% |
|---|---|---|---|
| Scientist II | 1 | $85,010 | — |
Where Contemporaries, Inc.'s H-1B roles are based
- Bethesda 20892, MD — 1
Other H-1B sponsors for Scientist IIs
| Employer | Filings for this role | Median wage |
|---|---|---|
| Eurofins BioPharma Product Testing Columbia, LLC. | 12 | $50,000 |
| University of Wisconsin System | 12 | $82,694 |
| Eurofins Professional Scientific Services Mid-Atlantic, LLC. | 11 | $51,356 |
| ALLEN INSTITUTE | 4 | $117,219 |
| Dana-Farber Cancer Institute | 4 | $85,000 |
| Eurofins Professional Scientific Services New England, LLC. | 4 | $57,907 |
| Eurofins Lancaster Laboratories LLC | 4 | $51,127 |
| Frontage Laboratories, Inc. | 4 | $77,782 |
All 62 sponsors for Scientist IIs →
Questions
Does Contemporaries, Inc. sponsor H-1B visas?
Rarely. Contemporaries, Inc. has filed a small number of H-1B applications: 1 certified H-1B labor condition applications (LCAs) in Department of Labor data for Oct 2025 – Jun 2026. An LCA is filed before an H-1B petition, so it is a strong sign of sponsorship but not a guarantee.
How much does Contemporaries, Inc. pay H-1B workers?
Median wages stated on Contemporaries, Inc.'s certified LCAs range from $85,010 to $85,010 a year across its most common roles; Scientist II had a median of $85,010.
Which roles does Contemporaries, Inc. sponsor?
The most frequent job titles on Contemporaries, Inc.'s LCAs are Scientist II.
Source: U.S. Department of Labor, Office of Foreign Labor Certification — LCA disclosure data, Oct 2025 – Jun 2026. An LCA (Labor Condition Application) is the step an employer files before an H-1B petition; a certified LCA is not a visa approval, and past filings don't guarantee an employer will sponsor you. Salaries are the wages employers stated on the LCAs. Offerbound is not affiliated with the companies listed.